16:00 EDT Insmed (INSM) trading halted, news pending
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSM:
- Insmed price target raised to $212 from $203 at RBC Capital
- Insmed price target raised to $237 from $231 at Barclays
- Insmed upgraded to Overweight from Equal Weight at Morgan Stanley
- Insmed price target raised to $245 from $230 at H.C. Wainwright
- Insmed price target raised to $206 from $204 at Mizuho